A tRNA-derived small RNAs expression signature as a predictive and prognostic biomarker in Diffuse Large B Cell Lymphoma

Tafasitamab的中国真实世界数据

初诊伴有弥漫大B细胞成分的中国滤泡淋巴瘤患者的临床特征及生存分析

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma

Ixazomib versus Lenalidomide or Ixazomib and Lenalidomide combination as maintenance regimen for transplant-ineligible multiple myeloma: update of a multi-center prospective study in China

淋巴瘤CAR-T治疗中的T细胞功能缺陷评估模型研究

动态循环肿瘤DNA揭示B细胞非霍奇金淋巴瘤患者CAR-T细胞治疗失败的机制研究

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy

Clinical and biological features and outcomes of patients with chronic lymphocytic leukemia: a real-world study of 2005 patients in China

整合多组学技术解析CLL泽布替尼耐药的克隆演变模式及耐药克隆特征

肿瘤外泌体通过CD19诱导CAR-T初始激活但通过TGFβ信号传导损害CAR-T细胞功能

派安普利单抗联合利妥昔单抗、甲氨蝶呤及阿糖胞苷（Pen-RMA）治疗初诊原发中枢神经系统淋巴瘤（PCNSL）的有效性及安全性的II期临床研究（NCT05347641）